BROMO-3-((4-NITROPHENOXY)IMINO)-5.ALPHA.-ANDROSTAN-17-ONE, 2.ALPHA.-
UNII 3LCE9UV36L
Substance Identification & Data
This profile provides standardized clinical and technical data for Bromo-3-((4-nitrophenoxy)imino)-5.alpha.-androstan-17-one, 2.alpha.-, uniquely identified by the FDA Unique Ingredient Identifier (UNII) 3LCE9UV36L.
Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 51354-35-9 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.
Detailed Substance Profile
C25H31BrN2O4 VAVMQQNNCHMREK-NCIANOTLSA-N Synonyms and Nomenclature
This section provides a complete list of nomenclature and identifier mappings for Bromo-3-((4-nitrophenoxy)imino)-5.alpha.-androstan-17-one, 2.alpha.-. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.